MRCP UK EXAMINATIONS

Detailed explanation-1: -LMWH is administered via subcutaneous route. This can be achieved by either by rotating injection sites or by injecting into an insuflonTM catheter. Direct subcutaneous injection should be given into a subcutaneous tissue skinfold of the abdomen or the upper-outer aspect of the thigh.

Detailed explanation-2: -Although LMWH and UFH work similarly to inhibit clotting factors, LMWH can be self-administered at home via subcutaneous (under the skin) injection and does not require regular blood monitoring necessary for UFH treatment.

Detailed explanation-3: -Low-molecular-weight heparin has excellent bioavailability when given by subcutaneous injection and can be administered once or twice daily. Its anticoagulant effect is related to body weight, thereby permitting a weight-based dosing regimen, and monitoring of aPTT is unnecessary.

Detailed explanation-4: -Heparin is an anticoagulant medication that is usually injected subcutaneously.